Live Nasdaq Composite: Chip Stocks Buckle Under Capex Pressure as Markets Hunt Leadership

Investing

AbbVie : ABBV

All AbbVie Articles

613 Articles

Lee Jackson | Apr 25, 2025 at 6:41 AM EDT

5 Rock-Solid Passive Income Dividend Aristocrats That Are Reasonably Safe From Tariffs

These five Dividend Aristocrats have the least negligible impact from the tariffs and are ideal for passive income investors.

Lee Jackson | Apr 18, 2025 at 8:47 AM EDT

One Sector Paying Big Dividends Is Off to the Best Start in 25 Years Despite Tariffs

Four healthcare dividend stocks with significant upside potential and safe dividends look like outstanding ideas for investors worn out from…

Omor Ibne Ehsan | Apr 15, 2025 at 8:51 AM EDT

iShares’ High-Yield HDV ETF – 7 Picks Powering Its High Yields

If you want a way to combine steady income, stability, and diversification, an exchange-traded fund (ETF) can deliver all three.…

Rich Duprey | Apr 10, 2025 at 12:12 PM EDT

4 Reasons Schwab’s High-Yield SCHD ETF Is the Safest Bet Today

Yesterday’s wild rally in the stock market where $5.5 trillion in value following President Trump hitting a 90-day pause on…

Vandita Jadeja | Apr 10, 2025 at 10:11 AM EDT

Vanguard’s High-Yield VYM ETF – 6 Stocks Driving Its Big Payouts

Investing isn’t easy, and given the current market volatility, retail investors are on edge, worrying about their portfolios. About 20%…

Lee Jackson | Apr 4, 2025 at 4:44 PM EDT

4 Blue Chip Pharmaceutical High-Yield Dividend Stocks Are Tariff Winners

Large-cap pharmaceutical stocks like these may now be positioned to outperform as the impact of tariffs begins to take hold.

David Moadel | Mar 20, 2025 at 1:51 PM EDT

Here Is Why Yield Hungry Investors Should Buy Schwab’s SCHD Over The Safe Vanguard VIG

In the 2020s, there are plenty of yield-focused exchange traded funds (ETFs) to choose from, and they’re not all created…

Rich Duprey | Mar 18, 2025 at 11:26 AM EDT

Only Have $500? 3 No-Brainer Stocks to Buy Right Now

Forget the old adage “it takes money to make money.” In the stock market, even a measly $500 can kickstart…

Will Ashworth | Mar 17, 2025 at 3:01 PM EDT

Billionaire Healthcare Investor Alex Denner’s Hedge Fund Has 75% of Its Assets in These 3 Stocks

If you work in the biotech industry, you might know the name Alex Denner. If not, his name probably doesn’t…

Trey Thoelcke | Mar 4, 2025 at 8:45 AM EST

Johnson & Johnson Just Paid Investors: Here’s How Much They Got

Johnson & Johnson has rewarded shareholders again with a quarterly dividend. As a Dividend King, it is the epitome of…

Lee Jackson | Mar 3, 2025 at 10:32 AM EST

Market Correction Wake-Up Call? 4 Dependable High-Yield Dividend Kings to the Rescue

One solid idea for growth and income investors who want to stay invested but shift to a more balanced approach…

Trey Thoelcke | Feb 14, 2025 at 8:45 AM EST

AbbVie Just Paid Investors: Here’s How Much They Received

AbbVie just rewarded its shareholders again with a dividend. This stock has boosted its payout annually for more than 50…

Rich Duprey | Jan 31, 2025 at 11:18 AM EST

AbbVie (ABBV) Earnings Live: Why The Stock Is Up Big Today

Shares of AbbVie (NYSE:ABBV | ABBV Price Prediction) are surging 7% this morning after the pharmaceutical giant reported solid fourth…

Trey Thoelcke | Jan 8, 2025 at 7:45 AM EST

Merck Just Paid Investors: How Much Did They Receive?

Merck just rewarded its shareholders again with a dividend hike. This Dow Jones industrial stock has come with a quarterly…

Trey Thoelcke | Dec 10, 2024 at 10:15 AM EST

Johnson & Johnson Just Paid Investors: Here’s How Much They Received

Johnson & Johnson has rewarded shareholders again with a quarterly dividend. As a Dividend King, it is the epitome of…

1 … 6 7 8 9 10 … 41

AbbVie : ABBV

All AbbVie Articles

5 Rock-Solid Passive Income Dividend Aristocrats That Are Reasonably Safe From Tariffs

One Sector Paying Big Dividends Is Off to the Best Start in 25 Years Despite Tariffs

iShares’ High-Yield HDV ETF – 7 Picks Powering Its High Yields

4 Reasons Schwab’s High-Yield SCHD ETF Is the Safest Bet Today

Vanguard’s High-Yield VYM ETF – 6 Stocks Driving Its Big Payouts

4 Blue Chip Pharmaceutical High-Yield Dividend Stocks Are Tariff Winners

Here Is Why Yield Hungry Investors Should Buy Schwab’s SCHD Over The Safe Vanguard VIG

Only Have $500? 3 No-Brainer Stocks to Buy Right Now

Billionaire Healthcare Investor Alex Denner’s Hedge Fund Has 75% of Its Assets in These 3 Stocks

Johnson & Johnson Just Paid Investors: Here’s How Much They Got

Market Correction Wake-Up Call? 4 Dependable High-Yield Dividend Kings to the Rescue

AbbVie Just Paid Investors: Here’s How Much They Received

AbbVie (ABBV) Earnings Live: Why The Stock Is Up Big Today

Merck Just Paid Investors: How Much Did They Receive?

Johnson & Johnson Just Paid Investors: Here’s How Much They Received

Live Nasdaq Composite: Chip Stocks Buckle Under Capex Pressure as Markets Hunt Leadership

Here’s Why SoFi Is a Prime Takeover Target for These Major Financial Players

Price Prediction: ASML Could Hit $2,000+ in 12 Months With AI Demand Fueling Lithography Growth

XYLD Versus SPY: The 28% Price Return Gap Nobody Discusses

She Moved to Vermont to Be Near the Grandkids. Now Her New State Taxes Her Social Security Check.

High Earners Lose $1,900 in 401(k) Tax Breaks: The HSA Strategy That Replaces It

Here’s Why SoFi Is a Prime Takeover Target for These Major Financial Players

Price Prediction: ASML Could Hit $2,000+ in 12 Months With AI Demand Fueling Lithography Growth

AbbVie : ABBV

All AbbVie Articles

5 Rock-Solid Passive Income Dividend Aristocrats That Are Reasonably Safe From Tariffs

One Sector Paying Big Dividends Is Off to the Best Start in 25 Years Despite Tariffs

iShares’ High-Yield HDV ETF – 7 Picks Powering Its High Yields

4 Reasons Schwab’s High-Yield SCHD ETF Is the Safest Bet Today

Vanguard’s High-Yield VYM ETF – 6 Stocks Driving Its Big Payouts

4 Blue Chip Pharmaceutical High-Yield Dividend Stocks Are Tariff Winners

Here Is Why Yield Hungry Investors Should Buy Schwab’s SCHD Over The Safe Vanguard VIG

Only Have $500? 3 No-Brainer Stocks to Buy Right Now

Billionaire Healthcare Investor Alex Denner’s Hedge Fund Has 75% of Its Assets in These 3 Stocks

Johnson & Johnson Just Paid Investors: Here’s How Much They Got

Market Correction Wake-Up Call? 4 Dependable High-Yield Dividend Kings to the Rescue

AbbVie Just Paid Investors: Here’s How Much They Received

AbbVie (ABBV) Earnings Live: Why The Stock Is Up Big Today

Merck Just Paid Investors: How Much Did They Receive?

Johnson & Johnson Just Paid Investors: Here’s How Much They Received

Live Nasdaq Composite: Chip Stocks Buckle Under Capex Pressure as Markets Hunt Leadership

Here’s Why SoFi Is a Prime Takeover Target for These Major Financial Players

Price Prediction: ASML Could Hit $2,000+ in 12 Months With AI Demand Fueling Lithography Growth

XYLD Versus SPY: The 28% Price Return Gap Nobody Discusses

Featured Reads

She Moved to Vermont to Be Near the Grandkids. Now Her New State Taxes Her Social Security Check.

High Earners Lose $1,900 in 401(k) Tax Breaks: The HSA Strategy That Replaces It